Cantargia AB (publ) (STO:CANTA)
Sweden
· Delayed Price · Currency is SEK 3.970
-0.125 (-3.05%)
Mar 9, 2026, 5:29 PM CET
Cantargia AB Revenue
In the year 2025, Cantargia AB had annual revenue of 316.70M SEK. Cantargia AB had revenue of 8.01M in the quarter ending December 31, 2025.
Revenue
316.70M
Revenue Growth
n/a
P/S Ratio
3.12
Revenue / Employee
14.40M
Employees
22
Market Cap
986.99M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xspray Pharma AB | 6.43M |
| Genovis AB (publ.) | 129.65M |
| Medivir AB | 8.50M |
| BioInvent International AB | 226.50M |
| Infant Bacterial Therapeutics AB | -1.00K |
| FluoGuide | 318.79K |
| Saniona AB | 434.40M |
| Diamyd Medical AB | 349.00K |
Cantargia AB News
- 16 days ago - Cantargia AB (FRA:7V3) Q4 2025 Earnings Call Highlights: A Year of First-Time Profitability ... - GuruFocus
- 17 days ago - Q4 2025 Cantargia AB Earnings Call Transcript - GuruFocus
- 3 months ago - Cantargia AB (FRA:7V3) Q3 2025 Earnings Call Highlights: First-Ever Profits and Promising ... - GuruFocus
- 3 months ago - Q3 2025 Cantargia AB Earnings Call Transcript - GuruFocus
- 1 year ago - Cantargia AB (FRA:7V3) Q3 2024 Earnings Call Highlights: Strategic Shifts and Financial Updates - GuruFocus
- 1 year ago - Q3 2024 Cantargia AB Earnings Call Transcript - GuruFocus